Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo
Yuan-Yuan Zhao,1,* Ying Tian,1,* Jing Zhang,2,* Fei Xu,1 Yun-Peng Yang,1 Yan Huang,1 Hong-Yun Zhao,3 Jian-Wei Zhang,4 Cong Xue,1 Michael H Lam,5 Li Yan,5 Zhi-Huang Hu,1 Xiao-Xiao Dinglin,6 Li Zhang1,3 1Department of Medical Oncology, Sun Yat-Sen University Cancer Center,...
Main Authors: | Zhao YY, Tian Y, Zhang J, Xu F, Yang YP, Huang Y, Zhao HY, Zhang JW, Xue C, Lam MH, Yan L, Hu ZH, Dinglin XX, Zhang L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/effects-of-an-oral-allosteric-akt-inhibitor-mk-2206-on-human-nasophary-peer-reviewed-article-DDDT |
Similar Items
-
Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
by: Alok Pant, et al.
Published: (2012-01-01) -
Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
by: Chen Y, et al.
Published: (2020-12-01) -
Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells
by: Cholpon S. Djuzenova, et al.
Published: (2019-04-01) -
An Akt inhibitor MK-2206 enhances the cytotoxicity of taxol and cisplatin in ovarian cancer cells
by: Ying-Hsi Lin, et al.
Published: (2011) -
In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma
by: Xue C, et al.
Published: (2016-03-01)